KRAS and colorectal cancer: Colorectal cancer cells were all highly sensitive to killing by reovirus-activated NK cells regardless of KRAS genotype or EGFR expression level, and reovirus further enhanced NK-cell cytotoxicity against cetuximab-coated colorectal cancer cells (Fig. 2a, b).